Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver

por KyeongJin Kim, Jin Ku Kang, Young Hoon Jung, Sang Bae Lee, Raffaela Rametta, Paola Dongiovanni, Luca Valenti, Utpal B. Pajvani
Publicado 2021

PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.

por Luca Valenti, Benedetta Maria Motta, Giorgio Soardo, Massimo Iavarone, Benedetta Donati, Angelo Sangiovanni, Alessia Carnelutti, Paola Dongiovanni, Raffaela Rametta, Cristina Bertelli, Floriana Facchetti, Massimo Colombo, Silvia Fargion, Anna Ludovica Fracanzani
Publicado 2013

Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma

por Alessandra Scagliola, Annarita Miluzio, Gabriele Ventura, Stefania Oliveto, Chiara Cordiglieri, Nicola Manfrini, Delia Cirino, Sara Ricciardi, Luca Valenti, Guido Baselli, Roberta D’Ambrosio, Marco Maggioni, Daniela Brina, Alberto Bresciani, Stefano Biffo
Publicado 2021

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals

por Benedetta Donati, Paola Dongiovanni, Stefano Romeo, Marica Meroni, Misti McCain, Luca Miele, Salvatore Petta, Silvia Maier, Chiara Rosso, Laura De Luca, Ester Vanni, Stefania Grimaudo, Renato Romagnoli, Fabio Colli, Flaminia Ferri, Rosellina Margherita Mancina, Paula Iruzubieta, Antonio Craxi, Anna Ludovica Fracanzani, Antonio Grieco, Stefano Ginanni Corradini, Alessio Aghemo, Massimo Colombo, Giorgio Soardo, Elisabetta Bugianesi, Helen Reeves, Quentin M. Anstee, Silvia Fargion, Luca Valenti
Publicado 2017